A Food and Drug Administration advisory panel last week recommended loosening compounding restrictions for six out of seven peptides it reviewed, despite safety and efficacy concerns expressed by agency scientists
Noopept appears to have neuroprotective and cognition-enhancing properties, but it belongs to the nootropic family of drugs known as racetams.98 While there isnt much data on Noopepts safety, specifically, other racetams, like Piracetam, can lead to psychomotor agitation, dysphoria, tiredness, dizziness, forgetfulness, headaches, and digestive upset.99 So, until we know more about Noopepts safety, it may be best to assume that it, too, can lead to similar adverse effects
Express Scripts requires BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
GIP has been shown to decrease food intake & increase energy expenditure therefore resulting in weight reductions & when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose, & lipides